spravato esketamine (as hydrochloride) 28 mg per 2 actuations nasal spray solution
janssen-cilag pty ltd - esketamine hydrochloride, quantity: 32.3 mg (equivalent: esketamine, qty 28 mg) - spray, nasal - excipient ingredients: disodium edetate; citric acid monohydrate; water for injections; sodium hydroxide - spravato is indicated for treatment resistant depression (major depressive disorder in adults who have not responded adequately to at least two different antidepressants of adequate dose and duration to treat the current moderate to severe depressive episode).,spravato is to be initiated in conjunction with a newly initiated oral antidepressant.
duloxetine 30 milligram capsules gastro-resistant
actavis group ptc ehf - duloxetine hydrochloride - capsules gastro-resistant - 30 milligram - other antidepressants - other antidepressants - it is indicated for: treatment of major depressive disorder; reatment of diabetic peripheral neuropathic pain; treatment of generalised anxiety disorder
duloxetine 60 milligram capsules gastro-resistant
actavis group ptc ehf - duloxetine hydrochloride - capsules gastro-resistant - 60 milligram - other antidepressants - other antidepressants - it is indicated for treatment of major depressive disorder; treatment of diabetic peripheral neuropathic pain; treatment of generalised anxiety disorder
trazodone hydrochloride 50/5 mg/ml oral solution
kinedexe uk limited - trazodone hydrochloride - oral solution - 50/5 mg/ml - other antidepressants - other antidepressants - relief of symptoms in all types of depression including depression accompanied by anxiety. symptoms of depression likely to respond in the first week of treatment include depressed mood, insomnia, anxiety, somatic symptoms and hypochondriasis.
xeplion 50 mg
j-c health care ltd - paliperidone as palmitate - suspension for injection extended release - paliperidone as palmitate 100 mg / 1 ml - paliperidone - paliperidone - xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.xeplion is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants
xeplion 100 mg
j-c health care ltd - paliperidone as palmitate - suspension for injection extended release - paliperidone as palmitate 100 mg / 1 ml - paliperidone - xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.xeplion is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants
xeplion 150 mg
j-c health care ltd - paliperidone as palmitate - suspension for injection extended release - paliperidone as palmitate 100 mg / 1 ml - paliperidone - xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.xeplion is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants
xeplion 75 mg
j-c health care ltd - paliperidone as palmitate - suspension for injection extended release - paliperidone as palmitate 100 mg / 1 ml - paliperidone - xeplion is indicated for the acute and maintenance treatment of schizophrenia in adults.xeplion is indicated for the treatment of schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers and antidepressants
duloxetine 60mg gastro-resistant capsules
consilient health limited - duloxetine - gastro-resistant capsule, hard - 60mg - antidepressants, other antidepressants - treatment of major depressive disorder. treatment of diabetic peripheral neuropathic pain. treatment of generalised anxiety disorder.
venzip xl 150mg prolonged-release capsules, hard
uk_ milpharm limited - venlafaxine (as hydrochloride) - prolonged-release tablet, hard - 150mg - antidepressants, other antidepressants - treatment of major depressive episodes. for prevention of recurrence of major depressive episodes. treatment of generalised anxiety disorder. treatment of social anxiety disorder. treatment of panic disorder, with or without agoraphobia.